← Back to Search

Camu Camu Capsules for HIV Suppression

Phase 1
Waitlist Available
Led By Jean-Pierre Routy, MD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if taking Camu Camu (CC) capsules can help people with HIV reduce inflammation. The goal is to see if CC increases good gut bacteria, which may protect the gut and lower inflammation. Participants will take CC for a few months, and researchers will check their blood and stool for changes.

Eligible Conditions
  • HIV Suppression
  • Human Immunodeficiency Virus Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Safety and tolerability of CC

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Camu CamuExperimental Treatment1 Intervention
Assessments will be done at baseline, during and after 12 weeks of Camu Camu intake.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Camu Camu Capsules
2020
Completed Phase 1
~30

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
470 Previous Clinical Trials
166,939 Total Patients Enrolled
Jean-Pierre Routy, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
3 Previous Clinical Trials
119 Total Patients Enrolled
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top